Metabolites from Actinomyces strain H6552 extract inhibit transforming growth factor mediated pulmonary fibrosis

QR Code

Metabolites from Actinomyces strain H6552 extract inhibit transforming growth factor mediated pulmonary fibrosis

Purpose: To evaluate the effects of H6552 extract in inhibiting transforming growth factor (TGF)-mediated pulmonary fibrosis in vitro and in vivo. Methods: Maximum-nontoxic dose (MNTD) of Actinomyces H6552 extract was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphhenyltetrazolium bromide (M...

Full description

Bibliographic Details
Main Authors:	Koh, Rhun Yian, Lim, Chooi Ling, Ho, Coy Choke, Uhal, Bruce David, Abdullah, Maha, Vidyadaran, Sharmili, Seow, Heng Fong
Format:	Article
Published:	Pharmacotherapy Group, Faculty of Pharmacy, University of Benin 2014
Online Access:	http://psasir.upm.edu.my/id/eprint/34496/

Similar Items

Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis
by: Koh, Rhun Yian, et al.
Published: (2015)

Refining in-vivo models of pulmonary fibrosis
by: Habgood, Anthony
Published: (2018)

Antifibrotic Effect of Transforming Growth Factor Beta 1 Inhibitor Extract from Streptomyces SP.Strain H6552 on Human Hepatic Stellate Cells
by: Lim, Chooi Ling
Published: (2010)

Differences in Response to Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
by: Kuzu, R., et al.
Published: (2011)

Genome comparison of Actinomyces naeslundii with known probiotics
by: Wan Mohd Kamaluddin, Wan Nur Fatihah, et al.
Published: (2019)

Actinomyces infection of the mastoid: a rare entity
by: Subha, Sethu Thakachy, et al.
Published: (2004)

International comparative epidemiology of idiopathic pulmonary fibrosis
by: Hutchinson, John
Published: (2017)

Mesenchymal stem cells inhibit proliferation of lymphoid origin haematopoietic tumour cells by inducing cell cycle arrest
by: Sarmadi, Vahid Hosseinpour, et al.
Published: (2010)

Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
by: Kozu, R., et al.
Published: (2011)

Isolation of a potential anticancer agent with protein phosphatase inhibitory activity from soil-derived Penicillium sp. strain H9318
by: Ooi, S. C., et al.
Published: (2016)

Genome comparison of Actinomyces naeslundii with 25 known probiotics
by: Othman, Noratikah, et al.
Published: (2019)

The role of galectin-3 in the development of idiopathic pulmonary fibrosis
by: Parmar, Nimesh
Published: (2019)

The role of Interleukin-33 in the development of idiopathic pulmonary fibrosis
by: Stephenson, Katherine
Published: (2021)

Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
by: Hurley, M., et al.
Published: (2015)

Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)

Suspected neonatal isoerythrolysis with concurrent Actinomyces hyovaginalis in a foal
by: Lim, Eric Teik Chung, et al.
Published: (2018)

The role of mesenchymal G proteins in pulmonary fibrosis and lung development
by: Goodwin, Amanda T.
Published: (2021)

Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis
by: Hobbs, Brian D., et al.
Published: (2017)

Interstitial pulmonary fibrosis in a Malaysian captive Asian elephant (Elephas maximus)
by: Yakubu, Yusuf, et al.
Published: (2014)

Co-aggregation: Interaction of Candida albicans, Actinomyces naeslundii and Streptococcus mutans
by: Arzmi, Mohd Hafiz, et al.
Published: (2014)

Intragenic and intergenic coaggregation of Candida albicans, Actinomyces naeslundii and Streptococcus mutans
by: Arzmi, Mohd Hafiz, et al.
Published: (2013)

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
by: Hutchinson, John P., et al.
Published: (2015)

The potential therapeutic effect of manipulating the extracellular matrix in idiopathic pulmonary fibrosis
by: Philp, Christopher J.
Published: (2016)

Progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection
by: Simpson, S., et al.
Published: (2015)

Differential expression of VEGF-Axxx isoforms is critical for development of pulmonary fibrosis
by: Barratt, Shaney L., et al.
Published: (2017)

Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century
by: Hutchinson, John P., et al.
Published: (2014)

cAMP mediated regulation of fibroblast to myofibroblast differentiation in idiopathic pulmonary fibrosis
by: Wright, Rebecca
Published: (2016)

Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study
by: Dalleywater, William, et al.
Published: (2014)

Effect of epigenetic inhibitors on lung fibroblast phenotype change in idiopathic pulmonary fibrosis
by: Pasini, Alice, et al.
Published: (2016)

Investigations into novel small molecules as potential treatments for idiopathic pulmonary fibrosis and malaria
by: Park, Jozef
Published: (2022)

Effect of epigenetic inhibitors on lung fibroblast phenotype change in idiopathic pulmonary fibrosis
by: Pasini, Alice, et al.
Published: (2016)

Immunomodulatory potential of mesenchymal stem cells on microglia
by: Vidyadaran, Sharmili, et al.
Published: (2012)

Coaggregation of Candida albicans, Actinomyces naeslundii and Streptococcus mutans is Candida albicans strain dependent
by: Arzmi, Mohd Hafiz, et al.
Published: (2015)

Suberanilohydroxamic acid (SAHA) inhibits collagen deposition in a transforming growth factor β1-driven precision cut lung slice (PCLS) model of pulmonary fibrosis
by: Brand, Oliver J., et al.
Published: (2016)

GSK3 inhibition reduces inflammatory responses of microglia and upregulates Il-10 production
by: Md Zain, Zuhaida, et al.
Published: (2017)

Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
by: Kozu, R., et al.
Published: (2010)

Antifungal compound and its production
by: Seow, Heng Fong, et al.
Published: (2010)

S52 Suberanilohydroxamic acid (SAHA) inhibits collagen deposition in a transforming growth factor β1-driven precision cut lung slice (PCLS) model of pulmonary fibrosis
by: Brand, Oliver J., et al.
Published: (2016)

Structure activity relationships of αv integrin antagonists for pulmonary fibrosis by variation in aryl substituents
by: Adams, James, et al.
Published: (2014)

Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study
by: Dallywater, William, et al.
Published: (2015)